Western blot analysis was performed as described previously (Wang et al., 2020 (link)). The following antibodies were used: Bcl-2 (#4223), Phospho-Bcl-2 (#2875), Bcl-xL (#2764), Bid (#2002), Bax (#5023), Bad (#9239), phospho-JNK (#4668), JNK (#9252), JNK1 (#3708), JNK2 (#9258), Cleaved Caspase-3 (#9664), PARP (#9532), phospho-c-Jun (Ser73) (#3270), phospho-c-Jun (Ser63) (#91952), c-Jun (#9165), PUMA (#4976), GAPDH (SC-47724). The antibodies were used at either 1:1,000 dilution or 1:2000 dilution. The GAPDH antibodies were purchased from Santa Cruz Biotechnology, and the rest of the antibodies were purchased from Cell Signaling Technology. The band intensity of the target protein was quantified using VisionWork LS image acquisition and analysis software (UVP).
Free full text: Click here